A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

(The Hill) — The popularity of drugs like Ozempic and Mounjaro could grow exponentially in the next few years, both for weight loss and a growing ... respectively, all fall within this class ...

“I think to really show a benefit for combining the two drugs we’re probably going to need to see the incremental weight loss ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...